Page last updated: 2024-10-24

celecoxib and Infection

celecoxib has been researched along with Infection in 1 studies

Research Excerpts

ExcerptRelevanceReference
"In this single-blind, controlled trial, consecutively hospitalized elderly patients (age > or = 70 years) with inflammation (C-reactive protein [CRP] levels > or =10 mg/L) due to acute infection were randomly assigned to receive 2 weeks of treatment with the COX-2-selective inhibitor celecoxib, acetaminophen, or no supplementary medication (control)."9.11The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. ( Bautmans, I; Demanet, C; Lambert, M; Mets, T; Njemini, R, 2004)
"In this single-blind, controlled trial, consecutively hospitalized elderly patients (age > or = 70 years) with inflammation (C-reactive protein [CRP] levels > or =10 mg/L) due to acute infection were randomly assigned to receive 2 weeks of treatment with the COX-2-selective inhibitor celecoxib, acetaminophen, or no supplementary medication (control)."5.11The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. ( Bautmans, I; Demanet, C; Lambert, M; Mets, T; Njemini, R, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mets, T1
Bautmans, I1
Njemini, R1
Lambert, M1
Demanet, C1

Trials

1 trial available for celecoxib and Infection

ArticleYear
The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation.
    The American journal of geriatric pharmacotherapy, 2004, Volume: 2, Issue:4

    Topics: Acute Disease; Aged; Aged, 80 and over; C-Reactive Protein; Celecoxib; Cyclooxygenase Inhibitors; Cy

2004